Cepheid

September 8, 2016
Danaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of Cepheid

Danaher Strengthens Molecular Diagnostics Portfolio with $4B Acquisition of Cepheid

Danaher has announced the acquisition of medical diagnostics company Cepheid, bolstering their presence in the Molecular Diagnostics market. Danaher Corporation will pay $53 per share in […]
March 17, 2016
Evolution M&A Analysis: Evaluating Potential Acquisition Targets for Thermo Fisher Scientific

Evolution M&A Analysis: Evaluating Potential Acquisition Targets for Thermo Fisher Scientific

A recent mixed securities shelf registration filing by Thermo Fisher Scientific has prompted speculation from industry insiders and investors, with prominent advisors predicting further acquisitions for […]
Contact Us